Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DBVT | NVCT |
|---|---|---|
| Price | $9.77 | $20.29 |
| Change today | ▼ 2.10% | ▲ 1.30% |
| Market cap | $614.03M | $662.35M |
| Return, 3 months | -39.2% | +6.8% |
| Return, year to date | -49.0% | +168.7% |
| Return, 1 year | -38.5% | +225.7% |
| P/E (TTM) | -2.8 | -15.4 |
| P/B | 3.8 | 73.0 |
| P/E percentile vs own 5y | 34th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -20.3% | -10.8% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -142.6% | -233.3% |
| Analyst target vs. price | +370.8% | +69.2% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 26 | 44 |
| 30-day volatility | 53.7% | 62.9% |
| Max drawdown, 1 year | -60.2% | -36.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
